GILD241206P85000
- 0.05
- 0.000.00%
Gilead Sciences Newsroom
Express News | Gilead : HSBC Raises Target Price to $82 From $69
Electronic Arts, Lyft and 7 More Stocks That Can Benefit From Trump's R&D Policy
Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today
Looking At Gilead Sciences's Recent Unusual Options Activity
Gilead Sciences(GILD.US) Officer Sells US$23.07 Million in Common Stock
Gilead Sciences Insider Sold Shares Worth $23,065,271, According to a Recent SEC Filing
Insider Sale: Chief Financial Officer of $GILD (GILD) Sells 127,930 Shares
Gilead Sciences, Inc. (GILD) Piper Sandler 36th Annual Healthcare Conference (Transcript)
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
Express News | Gilead Sciences Inc - Transaction Expected to Reduce Gilead's 2024 Gaap, Non-Gaap EPS by $0.01
Express News | Gilead Sciences Inc - Tubulis to Receive $20 Million Upfront Payment
Express News | Gilead and Tubulis Enter Into Exclusive Option and License Agreement to Develop ADC Candidate for Select Solid Tumor Target
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Gilead Sciences Ticks Upward for the Eight Consecutive Session
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
December Starts With a Mixed Market | Live Stock
Benign Growth For Gilead Sciences, Inc. (NASDAQ:GILD) Underpins Its Share Price
Express News | Gilead : Jefferies Raises Target Price to $115 From $105
Insider Sale: Chief Medical Officer of $GILD (GILD) Sells 3,199 Shares